Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Current Opinion in Neurology
|
October 13, 2022
Neurological adverse events of immune checkpoint blockade: from pathophysiology to treatment
Stefania Cuzzubbo, Antoine F Carpentier
La Revue Du Praticien
|
December 5, 2018
Glioblastomas: what’s new?
Stefania Cuzzubbo, Antoine F Carpentier
Cancers
|
April 3, 2021
Applications of Melanin and Melanin-Like Nanoparticles in Cancer Therapy: A Review of Recent Advances
Stefania Cuzzubbo, Antoine F Carpentier
Current Opinion in Neurology
|
August 1, 2025
Neurotoxicity from chimeric antigen receptor T-cells: an update on diagnosis and treatment
Renata Ursu, Stefania Cuzzubbo, Antoine F Carpentier
La Revue Du Praticien
|
October 23, 2025
[Outlook for the management of glioblastoma]
Nicolas Crainic, Renata Ursu, Stefania Cuzzubbo, et al.
Frontiers in Immunology
|
March 8, 2021
Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
Stefania Cuzzubbo, Sara Mangsbo, Divya Nagarajan, et al.
Cancer Immunology, Immunotherapy : CII
|
June 21, 2020
The adjuvant effect of melanin is superior to incomplete Freund's adjuvant in subunit/peptide vaccines in mice
Stefania Cuzzubbo, Claire Banissi, Marie Sophie Rouchon, et al.
International Journal of Molecular Sciences
|
December 11, 2022
Synthetic Melanin Acts as Efficient Peptide Carrier in Cancer Vaccine Strategy
Stefania Cuzzubbo, Benoit Roch, Guillaume Darrasse-Jèze, et al.
Neuro-Oncology
|
April 6, 2021
Evaluation of mid-term (6-12 months) neurotoxicity in B-cell lymphoma patients treated with CAR T cells: a prospective cohort study
Didier Maillet, Catherine Belin, Christine Moroni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 27, 2026
Optic neuropathies induced by immune checkpoint inhibitors: A case series and systematic review of the literature
Stefania Cuzzubbo, Alberto Vogrig, Evelaine Louis, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Current Opinion in Neurology
|
October 13, 2022
Neurological adverse events of immune checkpoint blockade: from pathophysiology to treatment
Stefania Cuzzubbo, Antoine F Carpentier
La Revue Du Praticien
|
December 5, 2018
Glioblastomas: what’s new?
Stefania Cuzzubbo, Antoine F Carpentier
Cancers
|
April 3, 2021
Applications of Melanin and Melanin-Like Nanoparticles in Cancer Therapy: A Review of Recent Advances
Stefania Cuzzubbo, Antoine F Carpentier
Current Opinion in Neurology
|
August 1, 2025
Neurotoxicity from chimeric antigen receptor T-cells: an update on diagnosis and treatment
Renata Ursu, Stefania Cuzzubbo, Antoine F Carpentier
La Revue Du Praticien
|
October 23, 2025
[Outlook for the management of glioblastoma]
Nicolas Crainic, Renata Ursu, Stefania Cuzzubbo, et al.
Frontiers in Immunology
|
March 8, 2021
Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
Stefania Cuzzubbo, Sara Mangsbo, Divya Nagarajan, et al.
Cancer Immunology, Immunotherapy : CII
|
June 21, 2020
The adjuvant effect of melanin is superior to incomplete Freund's adjuvant in subunit/peptide vaccines in mice
Stefania Cuzzubbo, Claire Banissi, Marie Sophie Rouchon, et al.
International Journal of Molecular Sciences
|
December 11, 2022
Synthetic Melanin Acts as Efficient Peptide Carrier in Cancer Vaccine Strategy
Stefania Cuzzubbo, Benoit Roch, Guillaume Darrasse-Jèze, et al.
Neuro-Oncology
|
April 6, 2021
Evaluation of mid-term (6-12 months) neurotoxicity in B-cell lymphoma patients treated with CAR T cells: a prospective cohort study
Didier Maillet, Catherine Belin, Christine Moroni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 27, 2026
Optic neuropathies induced by immune checkpoint inhibitors: A case series and systematic review of the literature
Stefania Cuzzubbo, Alberto Vogrig, Evelaine Louis, et al.
Page
of 3